Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thromboembolism 7Pulmonary Embolism 5Venous Thrombosis 4Neoplasms 4Neoplasm Metastasis 2Thrombosis 1Sarcoma 1Pancreatic Neoplasms 1Multiple Myeloma 1Mesenteric Ischemia 1Lymphoma 1Intracranial Thrombosis 1Fractures, Spontaneous 1Femoral Fractures 1Bone Neoplasms 1Acute Deep Vein Thrombosis 1

Interventions

apixaban 1Dalteparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Mesenteric Ischemia × Dalteparin × Clear all
NCT02585713 2020-08-04

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Academic and Community Cancer Research United

Phase 3 Completed
300 enrolled 11 charts
Classical hematology

Neoplasm Metastasis, Neoplasms, Pulmonary Embolism, Venous Thrombosis, Intracranial Thrombosis, Venous Thromboembolism, Mesenteric Ischemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡